PATENT CLAIM ANALYSIS

Application Number: 15872331
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "227800"]

Abstract:
The present invention is directed to compositions and methods for modulating c-Rel-dependent cytokine production without materially altering the level of expression of NFκB and/or the amount of IκB. The present invention is also directed to screening for modulators of c-Rel activity as determined by assaying for altered subcellular localization of c-Rel but where the level of expression of NFκB and/or the amount of IκB is materially unaltered.

Claim (Index 44):
The method of  claim 43 , wherein the neurological disease, disorder or condition is amyotrophic lateral sclerosis.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 86.0
- Lexical Diversity: 1.68293
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14542453', '13810668', '14449599', '14166681', '11478073']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6845143126235695
- 35 USC 102 Novelty (BERT): 0.5461661458024396
- Combined Prediction Score: 0.6706794959414565
- Mean Citation Score: 220.6252
- Max Citation Score: 410.61975
- Similarity Product: 230.45415527880192

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test